Have 0 4 0 4 O
been 5 9 5 9 O
diagnosed 10 19 10 19 O
with 20 24 20 24 O
a 25 26 25 26 O
malignancy 27 37 27 37 B-cancer
/ 37 38 37 38 O
tumor 38 43 38 43 B-cancer
/ 43 44 43 44 O
cancer 44 50 44 50 B-cancer
, 50 51 50 51 O
including 52 61 52 61 O
but 62 65 62 65 O
not 66 69 66 69 O
limited 70 77 70 77 O
to 78 80 78 80 O
: 80 81 80 81 O
brain 82 87 82 87 B-cancer
tumor 88 93 88 93 I-cancer
, 93 94 93 94 O
breast 95 101 95 101 B-cancer
cancer 102 108 102 108 I-cancer
, 108 109 108 109 O
lung 110 114 110 114 B-cancer
cancer 115 121 115 121 I-cancer
, 121 122 121 122 O
esophageal 123 133 123 133 B-cancer
cancer 134 140 134 140 I-cancer
, 140 141 140 141 O
lymphoma 142 150 142 150 B-cancer
, 150 151 150 151 O
or 152 154 152 154 O
sarcoma 155 162 155 162 B-cancer

Have 0 4 163 167 O
one 5 8 168 171 O
or 9 11 172 174 O
more 12 16 175 179 O
tumors 17 23 180 186 B-cancer
visualized 24 34 187 197 O
by 35 37 198 200 O
conventional 38 50 201 213 O
PET 51 54 214 217 O
- 54 55 217 218 O
CT 55 57 218 220 O
, 57 58 220 221 O
CT 59 61 222 224 O
or 62 64 225 227 O
magnetic 65 73 228 236 O
resonance 74 83 237 246 O
imaging 84 91 247 254 O
( 92 93 255 256 O
MRI 93 96 256 259 O
) 96 97 259 260 O
prior 98 103 261 266 O
to 104 106 267 269 O
the 107 110 270 273 O
PET 111 114 274 277 O
FMAU 115 119 278 282 O
study 120 125 283 288 O

Have 0 4 289 293 O
undergone 5 14 294 303 O
chemotherapy 15 27 304 316 B-treatment
or 28 30 317 319 O
radiation 31 40 320 329 B-treatment
therapy 41 48 330 337 I-treatment
within 49 55 338 344 O
the 56 59 345 348 O
previous 60 68 349 357 B-upper_bound
one 69 72 358 361 I-upper_bound
month 73 78 362 367 I-upper_bound

PET 0 3 368 371 B-treatment
- 3 4 371 372 I-treatment
CT 4 6 372 374 I-treatment
should 7 13 375 381 O
be 14 16 382 384 O
within 17 23 385 391 O
one 24 27 392 395 B-upper_bound
week 28 32 396 400 I-upper_bound
prior 33 38 401 406 I-upper_bound
to 39 41 407 409 O
18F 42 45 410 413 B-treatment
- 45 46 413 414 I-treatment
FMAU 46 50 414 418 I-treatment

Patients 0 8 419 427 O
who 9 12 428 431 O
have 13 17 432 436 O
had 18 21 437 440 O
surgery 22 29 441 448 B-treatment
at 30 32 449 451 O
the 33 36 452 455 O
site 37 41 456 460 O
of 42 44 461 463 O
the 45 48 464 467 O
suspected 49 58 468 477 O
lesion 59 65 478 484 O
within 66 72 485 491 O
1 73 74 492 493 B-upper_bound
month 75 80 494 499 I-upper_bound

Women 0 5 500 505 B-gender
of 6 8 506 508 O
childbearing 9 21 509 521 O
potential 22 31 522 531 O
, 31 32 531 532 O
unless 33 39 533 539 O
they 40 44 540 544 O
have 45 49 545 549 O
had 50 53 550 553 O
a 54 55 554 555 O
negative 56 64 556 564 O
urine 65 70 565 570 O
beta 71 75 571 575 O
human 76 81 576 581 O
chorionic 82 91 582 591 O
gonadotropin 92 104 592 604 O
( 105 106 605 606 O
betaHCG 106 113 606 613 O
) 113 114 613 614 O
within 115 121 615 621 O
the 122 125 622 625 O
previous 126 134 626 634 O
24 135 137 635 637 B-upper_bound
hours 138 143 638 643 I-upper_bound
of 144 146 644 646 O
the 147 150 647 650 O
procedure 151 160 651 660 O

